135 related articles for article (PubMed ID: 27237029)
1. DNMT3a expression pattern and its prognostic value in lung adenocarcinoma.
Husni RE; Shiba-Ishii A; Iiyama S; Shiozawa T; Kim Y; Nakagawa T; Sato T; Kano J; Minami Y; Noguchi M
Lung Cancer; 2016 Jul; 97():59-65. PubMed ID: 27237029
[TBL] [Abstract][Full Text] [Related]
2. Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
Sakurai H; Asamura H; Miyaoka E; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
Eur J Cardiothorac Surg; 2014 Jan; 45(1):100-7. PubMed ID: 23729748
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
Xu Y; Zhu C; Qian W; Zheng M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):181-186. PubMed ID: 27738759
[TBL] [Abstract][Full Text] [Related]
4. RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.
Calvayrac O; Pradines A; Raymond-Letron I; Rouquette I; Bousquet E; Lauwers-Cances V; Filleron T; Cadranel J; Beau-Faller M; Casanova A; Milia J; Favre G; Mazières J
Clin Cancer Res; 2014 Dec; 20(24):6541-50. PubMed ID: 25320360
[TBL] [Abstract][Full Text] [Related]
5. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
6. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
9. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
10. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
11. DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
Kataoka I; Funata S; Nagahama K; Isogaya K; Takeuchi H; Abe N; Shibahara J
Ann Diagn Pathol; 2020 Feb; 44():151456. PubMed ID: 31862523
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
13. O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
Wu PF; Kuo KT; Kuo LT; Lin YT; Lee WC; Lu YS; Yang CH; Wu RM; Tu YK; Tasi JC; Tseng HM; Tseng SH; Cheng AL; Lin CH
Lung Cancer; 2010 Jun; 68(3):484-90. PubMed ID: 19740564
[TBL] [Abstract][Full Text] [Related]
14. Cyclophilin A expression and its prognostic significance in lung adenocarcinoma.
Nakano N; Sakashita S; Matsuoka R; Murata Y; Shiba-Ishii A; Kobayashi N; Sato Y; Noguchi M
Pathol Int; 2017 Nov; 67(11):555-563. PubMed ID: 29027312
[TBL] [Abstract][Full Text] [Related]
15. Geminin expression in small lung adenocarcinomas: implication of prognostic significance.
Haruki T; Shomori K; Hamamoto Y; Taniguchi Y; Nakamura H; Ito H
Lung Cancer; 2011 Mar; 71(3):356-62. PubMed ID: 20650542
[TBL] [Abstract][Full Text] [Related]
16. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
17. Loss of TSLC1 expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance.
Goto A; Niki T; Chi-Pin L; Matsubara D; Murakami Y; Funata N; Fukayama M
Cancer Sci; 2005 Aug; 96(8):480-6. PubMed ID: 16108829
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
[TBL] [Abstract][Full Text] [Related]
19. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]